IMMUNOABLATIVE THERAPIEN

European patent · EP3632446 · In force

Register entry

Publication number
EP3632446
Application number
EP19201254
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Limited
Filed
Oct 3, 2019
Published
Apr 8, 2020
Granted
Jan 13, 2021
Protection ends at the latest
Oct 2, 2039
Next annual fee due
Oct 31, 2026
IPC classes
A61K 31/573 (2006.01)
A61P 37/06 (2006.01)
Priority
EP 18198491 03.10.2018
US 201816227068 20.12.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Apr 29, 2024

    Change

    Published in Swissreg on 29.04.2024

  4. Dec 27, 2023

    Change

    Published in Swissreg on 27.12.2023

  5. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  6. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  7. Nov 24, 2021

    Change

    Published in Swissreg on 24.11.2021

  8. Jan 13, 2021

    Granted

    Published in Swissreg on 13.01.2021

Parties

Holder

AVM Biotechnology, LLC

1749 Dexter Ave North, Seattle, WA 98109, US

Inventor

Deisher, Theresa

Seattle, WA Washington 98109, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.